Skip to content
10-Q

Quarterly Report

Baudax Bio, Inc.

0000950170-23-042918

← back to feed
Filed
Aug 16, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 8, 2023 6.97M sh
Shares Diluted Q2 2023 · Jun 30, 2023 4.89M sh
Shares Diluted Q2 2023 · Jun 30, 2023 3.6M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 179.54K sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 140.25K sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$7.31M
Operating Cash Flow restated Q2 2023 · Jun 30, 2022 −$10.01M
Long Term Debt Q2 2023 · Jun 30, 2023 $0
Long Term Debt Q2 2023 · Dec 31, 2022 $1.52M
Short Term Debt Q2 2023 · Jun 30, 2023 $4.86M
Short Term Debt Q2 2023 · Dec 31, 2022 $5.6M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $1.42M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $5.26M
Stockholders Equity Q2 2023 · Jun 30, 2023 −$10.68M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$7.31M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$24.24M
Stockholders Equity restated Q2 2023 · Jun 30, 2022 $4.23M
Stockholders Equity Q2 2023 · Mar 31, 2022 $9.74M
Stockholders Equity Q2 2023 · Dec 31, 2021 $13.23M
Current Liabilities Q2 2023 · Jun 30, 2023 $20.46M
Current Liabilities Q2 2023 · Dec 31, 2022 $21.46M
Total Liabilities Q2 2023 · Jun 30, 2023 $22.96M
Total Liabilities Q2 2023 · Dec 31, 2022 $34.27M
Current Assets Q2 2023 · Jun 30, 2023 $1.86M
Current Assets Q2 2023 · Dec 31, 2022 $6.35M
Total Assets Q2 2023 · Jun 30, 2023 $21.32M
Total Assets Q2 2023 · Dec 31, 2022 $10.03M
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.51
Eps Diluted Q2 2023 · Jun 30, 2023 $1.12
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$41.95
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$145.03
Eps Basic Q2 2023 · Jun 30, 2023 −$1.51
Eps Basic Q2 2023 · Jun 30, 2023 $1.12
Eps Basic restated Q2 2023 · Jun 30, 2022 −$41.95
Eps Basic restated Q2 2023 · Jun 30, 2022 −$145.03
Sga Expense Q2 2023 · Jun 30, 2023 $2.25M
Sga Expense Q2 2023 · Jun 30, 2023 $4.03M
Sga Expense restated Q2 2023 · Jun 30, 2022 $2.9M
Sga Expense restated Q2 2023 · Jun 30, 2022 $9.83M
Rd Expense Q2 2023 · Jun 30, 2023 $1.78M
Rd Expense Q2 2023 · Jun 30, 2023 $4.7M
Rd Expense restated Q2 2023 · Jun 30, 2022 $879K
Rd Expense restated Q2 2023 · Jun 30, 2022 $1.57M
Net Income Q2 2023 · Jun 30, 2023 −$7.38M
Net Income Q2 2023 · Jun 30, 2023 $4.03M
Net Income Q2 2023 · Mar 31, 2023 $11.4M
Net Income Q2 2023 · Jun 30, 2022 −$7.53M
Net Income Q2 2023 · Jun 30, 2022 −$20.34M
Net Income Q2 2023 · Mar 31, 2022 −$12.81M
Operating Income Q2 2023 · Jun 30, 2023 −$7.05M
Operating Income Q2 2023 · Jun 30, 2023 −$11.73M
Operating Income restated Q2 2023 · Jun 30, 2022 −$3.78M
Operating Income restated Q2 2023 · Jun 30, 2022 −$11.4M
Revenue Q2 2023 · Jun 30, 2023 $30K
Revenue Q2 2023 · Jun 30, 2023 $16K
Revenue Q2 2023 · Jun 30, 2022 $300K
Revenue Q2 2023 · Jun 30, 2022 $722K